[go: up one dir, main page]

NO20023117L - Sammensetning for forebygging og/eller behandling av lipidmetabolismeforstyrrelser og allergiske former - Google Patents

Sammensetning for forebygging og/eller behandling av lipidmetabolismeforstyrrelser og allergiske former

Info

Publication number
NO20023117L
NO20023117L NO20023117A NO20023117A NO20023117L NO 20023117 L NO20023117 L NO 20023117L NO 20023117 A NO20023117 A NO 20023117A NO 20023117 A NO20023117 A NO 20023117A NO 20023117 L NO20023117 L NO 20023117L
Authority
NO
Norway
Prior art keywords
prevention
treatment
composition
lipid metabolism
metabolism disorders
Prior art date
Application number
NO20023117A
Other languages
English (en)
Other versions
NO20023117D0 (no
Inventor
Pietro Pola
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20023117L publication Critical patent/NO20023117L/no
Publication of NO20023117D0 publication Critical patent/NO20023117D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20023117A 2000-11-17 2002-06-27 Sammensetning for forebygging og/eller behandling av lipidmetabolismeforstyrrelser og allergiske former NO20023117D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000602A IT1317938B1 (it) 2000-11-17 2000-11-17 Composizione per la prevenzione e/o il trattamento di alterazioni delmetabolismo lipidico, delle forme allergiche e per attivare le difese
PCT/IT2001/000394 WO2002040012A1 (en) 2000-11-17 2001-07-24 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms

Publications (2)

Publication Number Publication Date
NO20023117L true NO20023117L (no) 2002-06-27
NO20023117D0 NO20023117D0 (no) 2002-06-27

Family

ID=11455002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023117A NO20023117D0 (no) 2000-11-17 2002-06-27 Sammensetning for forebygging og/eller behandling av lipidmetabolismeforstyrrelser og allergiske former

Country Status (19)

Country Link
US (1) US7211571B2 (no)
EP (1) EP1257267B1 (no)
AT (1) ATE269073T1 (no)
AU (1) AU778952B2 (no)
CA (1) CA2406925A1 (no)
CZ (1) CZ20022307A3 (no)
DE (1) DE60103854T2 (no)
DK (1) DK1257267T3 (no)
ES (1) ES2222388T3 (no)
HU (1) HUP0204209A3 (no)
IL (1) IL150637A0 (no)
IT (1) IT1317938B1 (no)
MX (1) MXPA02007001A (no)
NO (1) NO20023117D0 (no)
PL (1) PL355200A1 (no)
PT (1) PT1257267E (no)
SK (1) SK10282002A3 (no)
TR (1) TR200401572T4 (no)
WO (1) WO2002040012A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
SG10201402287TA (en) 2009-05-11 2014-07-30 Berg Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
KR101933732B1 (ko) 2011-04-04 2018-12-28 버그 엘엘씨 중추 신경 시스템 종양들의 치료 방법
WO2014168993A1 (en) 2013-04-08 2014-10-16 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
ES2825083T3 (es) 2013-09-04 2021-05-14 Berg Llc Métodos de tratamiento contra el cáncer mediante infusión continua de coenzima Q10
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975421A (en) * 1985-08-19 1990-12-04 Bioglucan, Lp. Soluble phosphorylated glucan: methods and compositions for wound healing
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
SI0951909T2 (sl) 1998-03-19 2010-11-30 Sigma Tau Ind Farmaceuti Kombinirana zmes ki vsebuje L karnitin ali alkanoil L karnitin glikozaminoglikan in ali njegov sestavni del
AU2437101A (en) * 1999-12-16 2001-06-25 Harry Siskind Nutritional composition, methods of producing said composition and methods of using said composition

Also Published As

Publication number Publication date
CA2406925A1 (en) 2002-05-23
ITRM20000602A1 (it) 2002-05-17
EP1257267A1 (en) 2002-11-20
PL355200A1 (en) 2004-04-05
AU7667501A (en) 2002-05-27
IT1317938B1 (it) 2003-07-15
DE60103854T2 (de) 2005-07-14
WO2002040012A1 (en) 2002-05-23
DE60103854D1 (de) 2004-07-22
TR200401572T4 (tr) 2004-09-21
ES2222388T3 (es) 2005-02-01
US7211571B2 (en) 2007-05-01
US20030017999A1 (en) 2003-01-23
PT1257267E (pt) 2004-09-30
ATE269073T1 (de) 2004-07-15
CZ20022307A3 (cs) 2003-01-15
NO20023117D0 (no) 2002-06-27
HUP0204209A2 (hu) 2003-04-28
AU778952B2 (en) 2004-12-23
ITRM20000602A0 (it) 2000-11-17
IL150637A0 (en) 2003-02-12
MXPA02007001A (es) 2003-01-28
HUP0204209A3 (en) 2005-03-29
DK1257267T3 (da) 2004-10-25
SK10282002A3 (sk) 2003-03-04
EP1257267B1 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
BRPI0519265A2 (pt) composiÇÕes incluindo ferro
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
DK1408776T3 (da) Hidtil ukendte levnedsmiddelprodukter indeholdende betain
NO20006430L (no) Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner
ATE428699T1 (de) Pyrazolylderivative in form von arzneimitteln zur behandlung von akuten oder chronischen neuronalen regressionen
NL1025936A1 (nl) Vruchten van het genus Capsicum met verbeterde smaak en verhoogde voedingswaarde.
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
MX2009003202A (es) Tratamiento de jugos, extractos y pigmentos de plantas.
CA2485403A1 (en) Use of purslane to treat facial wrinkles
WO2006002909A3 (en) Sphingolipids against pathological processes in lipid rafts
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
NO20023117L (no) Sammensetning for forebygging og/eller behandling av lipidmetabolismeforstyrrelser og allergiske former
BR0215394A (pt) Polissacarìdeo negativamente carregado derivável de aloe vera
TW200508210A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
NO20021640D0 (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Ginko Biloba
DE69914360D1 (de) Chromone zubereitung zur enteralen wirkstofffreisetzung
BRPI0516996A (pt) produto aliementìcio contendo um ou vários microorganismos vivos e pelo menos um ingrediente aliementìcio bioativo de interesse, processo de encapsulação de pelo menos um ingrediente alimentìcio bioativo de interesse em uma matéria graxa, e, utilizações de um produto alimentìcio e de uma matéria graxa
WO2008051793A3 (en) Method of preventing or treating metabolic syndrome
WO2005076761A3 (en) Composition for preenting a cold
AU2003271807A8 (en) Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
ATE239504T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von störungen aufgrund von abnormalen fettstoffmetabolismus, enthaltend l-carnitin und chitosan
Nassarawa et al. Pharmacological Properties of Citrus Fruit
WO2004073613A3 (en) A medicine and food
CO5690572A2 (es) Composiciones nutraceuticas que comprenden galato de epigalo catequina y cetona de frambuesa